For country-level policymakers, the opportunity to introduce a new vaccine comes with many considerations. Is the vaccine needed? What are the benefits? Is there enough capacity in the cold chain system? Often most important—what will it cost, and can our country afford it? Adding complexity to complexity, new vaccine products and new formulations of existing vaccines continue to be developed and commercialized, which can make decisions more daunting when a country is choosing which vaccine product to introduce or switch to. This webinar illustrated how PATH’s new Vaccine Cost Calculators can help, providing an easy way for country-level decision-makers to assess and compare the costs of certain vaccination programs over a period of 10 years with each vaccine product available in the global market.
Watch the webinar recording here.